Halo Pharma - Whippany Halo Pharma will become a stand-alone business as a result of the sale of the Noramco API and associated business to Siegfried. SK Capital Partners have signed a definitive ...

According to multiple recent market analyses, the global API market is experiencing steady growth. One comprehensive forecast projects the global active pharmaceutical ingredient market to expand from ...

HANGZHOU, ZHEJIANG, CHINA, January 16, 2026 /EINPresswire.com/ -- The pharmaceutical industry is undergoing a period of ...

Ardena has completed the process of divesting its active pharmaceutical ingredient (API) site in Södertälje, Sweden, to Nanologica AB.

Halo Pharma becomes a standalone drug product CDMO after the sale of Noramco’s API assets, adding sterile services by H2 2026 ...

Enveda has been using AI to power its drug discovery platform for several years. The company injected $230 million into funding the process through June 2024. Meanwhile, Phlow grew its analytical ...

Market valued at $72.4M in 2024, projected 7.30% CAGR growth driven by pharmaceutical API synthesis, food-grade ...

Mordor Intelligence has published a new report on the Pharmaceutical Contract Manufacturing Organization (CMO) Market, offering a comprehensive analysis of trends, growth drivers, and future ...

HRV Pharma and Haleos Labs have joined forces in a multi-year strategic partnership to fast-track the development and manufacturing of specialized active pharmaceutical ingredients (APIs) for rare ...

Our Bureau, Bengaluru Tuesday, January 20, 2026, 16:30 Hrs [IST] ...

Under the agreement, the two companies will jointly undertake co-development of a multi-year pipeline of high-value specialty ...

The Fine and Specialty Chemicals Market is entering a transformative phase of high-value innovation and application-specific ...